{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T04:57:21Z","timestamp":1793681841725,"version":"4.5.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T00:00:00Z","timestamp":1610928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T00:00:00Z","timestamp":1610928000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["15H04655"],"award-info":[{"award-number":["15H04655"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["15J05263"],"award-info":[{"award-number":["15J05263"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Clinical successes demonstrated by chimeric antigen receptor T-cell immunotherapy have facilitated further development of T-cell immunotherapy against wide variety of diseases. One approach is the development of \u201coff-the-shelf\u201d T-cell sources. Technologies to generate T-cells from pluripotent stem cells (PSCs) may offer platforms to produce \u201coff-the-shelf\u201d and synthetic allogeneic T-cells. However, low differentiation efficiency and poor scalability of current methods may compromise their utilities. Here we show improved differentiation efficiency of T-cells from induced PSCs (iPSCs) derived from an antigen-specific cytotoxic T-cell clone, or from T-cell receptor (TCR)-transduced iPSCs, as starting materials. We additionally describe feeder-free differentiation culture systems that span from iPSC maintenance to T-cell proliferation phases, enabling large-scale regenerated T-cell production. Moreover, simultaneous addition of SDF1\u03b1 and a p38 inhibitor during T-cell differentiation enhances T-cell commitment. The regenerated T-cells show TCR-dependent functions in vitro and are capable of in vivo anti-tumor activity. This system provides a platform to generate a large number of regenerated T-cells for clinical application and investigate human T-cell differentiation and biology.<\/jats:p>","DOI":"10.1038\/s41467-020-20658-3","type":"journal-article","created":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T06:17:06Z","timestamp":1610950626000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":238,"title":["A clinically applicable and scalable method to regenerate T-cells from iPSCs for off-the-shelf T-cell immunotherapy"],"prefix":"10.1038","volume":"12","author":[{"given":"Shoichi","family":"Iriguchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Yasui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Kawai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suguru","family":"Arima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihoko","family":"Kunitomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuki","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsutaka","family":"Minagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4945-7346","authenticated-orcid":false,"given":"Yuta","family":"Mishima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nariaki","family":"Yanagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Baba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Miyake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhide","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maiko","family":"Takiguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tokuyuki","family":"Shinohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Nakatsura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1538-433X","authenticated-orcid":false,"given":"Masaki","family":"Yasukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Kassai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2291-4586","authenticated-orcid":false,"given":"Shin","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,18]]},"reference":[{"key":"20658_CR1","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.stem.2015.03.011","volume":"16","author":"M Themeli","year":"2015","unstructured":"Themeli, M., Rivi\u00e8re, I. & Sadelain, M. New cell sources for T cell engineering and adoptive immunotherapy. Cell Stem Cell 16, 357\u2013366 (2015).","journal-title":"Cell Stem Cell"},{"key":"20658_CR2","doi-asserted-by":"publisher","first-page":"6879","DOI":"10.4049\/jimmunol.0803670","volume":"182","author":"F Timmermans","year":"2009","unstructured":"Timmermans, F. et al. Generation of T cells from human embryonic stem cell-derived hematopoietic zones. J. Immunol. 182, 6879\u20136888 (2009).","journal-title":"J. Immunol."},{"key":"20658_CR3","first-page":"1722","volume":"2","author":"M Kennedy","year":"2012","unstructured":"Kennedy, M. et al. T lymphocyte potential marks the emergence of definitive hematopoietic progenitors in human pluripotent stem cell differentiation cultures. CellReports 2, 1722\u20131735 (2012).","journal-title":"CellReports"},{"key":"20658_CR4","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.stem.2012.11.002","volume":"12","author":"T Nishimura","year":"2013","unstructured":"Nishimura, T. et al. Generation of rejuvenated antigen-specific T cells by reprogramming to pluripotency and redifferentiation. Cell Stem Cell 12, 114\u2013126 (2013).","journal-title":"Cell Stem Cell"},{"key":"20658_CR5","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.stem.2013.03.001","volume":"12","author":"H Wakao","year":"2013","unstructured":"Wakao, H. et al. Expansion of functional human mucosal-associated invariant T cells via reprogramming to pluripotency and redifferentiation. Cell Stem Cell 12, 546\u2013558 (2013).","journal-title":"Cell Stem Cell"},{"key":"20658_CR6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.stem.2012.12.006","volume":"12","author":"R Vizcardo","year":"2013","unstructured":"Vizcardo, R. et al. Regeneration of human tumor antigen-specific T cells from iPSCs derived from mature CD8(+) T cells. Cell Stem Cell 12, 31\u201336 (2013).","journal-title":"Cell Stem Cell"},{"key":"20658_CR7","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1038\/nbt.2678","volume":"31","author":"M Themeli","year":"2013","unstructured":"Themeli, M. et al. Generation of tumor-targeted human T lymphocytes from induced pluripotent stem cells for cancer therapy. Nat. Biotechnol. 31, 928\u2013933 (2013).","journal-title":"Nat. Biotechnol."},{"key":"20658_CR8","doi-asserted-by":"publisher","first-page":"6839","DOI":"10.1158\/0008-5472.CAN-16-1149","volume":"76","author":"T Maeda","year":"2016","unstructured":"Maeda, T. et al. Regeneration of CD8\u03b1\u03b2 T Cells from T-cell-Derived iPSC Imparts Potent Tumor Antigen-Specific Cytotoxicity. Cancer Res. 76, 6839\u20136850 (2016).","journal-title":"Cancer Res."},{"key":"20658_CR9","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.stem.2018.10.005","volume":"23","author":"A Minagawa","year":"2018","unstructured":"Minagawa, A. et al. Enhancing T cell receptor stability in rejuvenated iPSC-derived T cells improves their use in cancer immunotherapy. Cell Stem Cell 23, 850\u2013858e4 (2018).","journal-title":"Cell Stem Cell"},{"key":"20658_CR10","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/nrm.2016.127","volume":"18","author":"A Ditadi","year":"2017","unstructured":"Ditadi, A., Sturgeon, C. M. & Keller, G. A view of human haematopoietic development from the petri dish. Nat. Rev. Mol. Cell Biol. 18, 56\u201367 (2017).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"20658_CR11","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1242\/dev.134866","volume":"144","author":"A Ivanovs","year":"2017","unstructured":"Ivanovs, A. et al. Human haematopoietic stem cell development: from the embryo to the dish. Development 144, 2323\u20132337 (2017).","journal-title":"Development"},{"key":"20658_CR12","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/nri913","volume":"2","author":"H Spits","year":"2002","unstructured":"Spits, H. Development of \u03b1\u03b2 T cells in the human thymus. Nat. Rev. Immunol. 2, 760\u2013772 (2002).","journal-title":"Nat. Rev. Immunol."},{"key":"20658_CR13","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1182\/blood-2004-04-1293","volume":"105","author":"RN La Motte-Mohs","year":"2005","unstructured":"La Motte-Mohs, R. N., Herer, E. & Z\u00fa\u00f1iga-Pfl\u00fccker, J. C. Induction of T-cell development from human cord blood hematopoietic stem cells by delta-like 1 in vitro. Blood 105, 1431\u20131439 (2005).","journal-title":"Blood"},{"key":"20658_CR14","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1182\/blood-2008-10-187013","volume":"114","author":"G Awong","year":"2009","unstructured":"Awong, G. et al. Characterization in vitro and engraftment potential in vivo of human progenitor T cells generated from hematopoietic stem cells. Blood 114, 972\u2013982 (2009).","journal-title":"Blood"},{"key":"20658_CR15","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1146\/annurev.immunol.23.021704.115715","volume":"25","author":"HT Petrie","year":"2007","unstructured":"Petrie, H. T. & Z\u00fa\u00f1iga-Pfl\u00fccker, J. C. Zoned out: functional mapping of stromal signaling microenvironments in the thymus. Annu. Rev. Immunol. 25, 649\u2013679 (2007).","journal-title":"Annu. Rev. Immunol."},{"key":"20658_CR16","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.stem.2018.12.011","volume":"24","author":"A Montel-Hagen","year":"2019","unstructured":"Montel-Hagen, A. et al. Organoid-induced differentiation of conventional T cells from human pluripotent stem cells. Cell Stem Cell 24, 376\u2013389.e8 (2019).","journal-title":"Cell Stem Cell"},{"key":"20658_CR17","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/nbt.2571","volume":"31","author":"CM Sturgeon","year":"2013","unstructured":"Sturgeon, C. M., Ditadi, A., Clarke, R. L. & Keller, G. Defining the path to hematopoietic stem cells. Nat. Biotechnol. 31, 416\u2013418 (2013).","journal-title":"Nat. Biotechnol."},{"key":"20658_CR18","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1038\/nbt.3702","volume":"34","author":"ES Ng","year":"2016","unstructured":"Ng, E. S. et al. Differentiation of human embryonic stem cells to HOXA+ hemogenic vasculature that resembles the aorta-gonad-mesonephros. Nat. Biotechnol. 34, 1168\u20131179 (2016).","journal-title":"Nat. Biotechnol."},{"key":"20658_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/srep03594","volume":"4","author":"M Nakagawa","year":"2014","unstructured":"Nakagawa, M. et al. A novel efficient feeder-free culture system for the derivation of human induced pluripotent stem cells. Sci. Rep. 4, 3594 (2014).","journal-title":"Sci. Rep."},{"key":"20658_CR20","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1182\/blood-2006-02-003327","volume":"108","author":"MA Vodyanik","year":"2006","unstructured":"Vodyanik, M. A., Thomson, J. A. & Slukvin, I. I. Leukosialin (CD43) defines hematopoietic progenitors in human embryonic stem cell differentiation cultures. Blood 108, 2095\u20132105 (2006).","journal-title":"Blood"},{"key":"20658_CR21","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1002\/stem.1145","volume":"30","author":"C Reimann","year":"2012","unstructured":"Reimann, C. et al. Human T-lymphoid progenitors generated in a feeder-cell-free delta-like-4 culture system promote T-cell reconstitution in NOD\/SCID\/\u03b3c\u2212\/\u2212 mice. Stem Cells 30, 1771\u20131780 (2012).","journal-title":"Stem Cells"},{"key":"20658_CR22","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1189\/jlb.1TA0214-121RR","volume":"96","author":"MJAJ Huijskens","year":"2014","unstructured":"Huijskens, M. J. A. J. et al. Technical advance: ascorbic acid induces development of double-positive T cells from human hematopoietic stem cells in the absence of stromal cells. J. Leukoc. Biol. 96, 1165\u20131175 (2014).","journal-title":"J. Leukoc. Biol."},{"key":"20658_CR23","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/nmeth.1591","volume":"8","author":"K Okita","year":"2011","unstructured":"Okita, K. et al. A more efficient method to generate integration-free human iPS cells. Nat. Methods 8, 409\u2013412 (2011).","journal-title":"Nat. Methods"},{"key":"20658_CR24","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/nbt0708-739","volume":"26","author":"N Nakatsuji","year":"2008","unstructured":"Nakatsuji, N., Nakajima, F. & Tokunaga, K. HLA-haplotype banking and iPS cells. Nat. Biotechnol. 26, 739\u2013740 (2008).","journal-title":"Nat. Biotechnol."},{"key":"20658_CR25","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.stem.2012.07.014","volume":"11","author":"CJ Taylor","year":"2012","unstructured":"Taylor, C. J., Peacock, S., Chaudhry, A. N., Bradley, J. A. & Bolton, E. M. Generating an iPSC bank for HLA-matched tissue transplantation based on known donor and recipient HLA types. Cell Stem Cell 11, 147\u2013152 (2012).","journal-title":"Cell Stem Cell"},{"key":"20658_CR26","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1182\/blood.V95.1.286","volume":"95","author":"H Ohminami","year":"2000","unstructured":"Ohminami, H., Yasukawa, M. & Fujita, S. HLA class I-restricted lysis of leukemia cells by a CD8(+) cytotoxic T-lymphocyte clone specific for WT1 peptide. Blood 95, 286\u2013293 (2000).","journal-title":"Blood"},{"key":"20658_CR27","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1182\/blood-2011-02-337089","volume":"118","author":"T Ochi","year":"2011","unstructured":"Ochi, T. et al. Novel adoptive T-cell immunotherapy using a WT1-specific TCR vector encoding silencers for endogenous TCRs shows marked antileukemia reactivity and safety. Blood 118, 1495\u20131503 (2011).","journal-title":"Blood"},{"key":"20658_CR28","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.4049\/jimmunol.155.6.2938","volume":"155","author":"T Sato","year":"1995","unstructured":"Sato, T., Tachibana, K., Nojima, Y., D\u2019Avirro, N. & Morimoto, C. Role of the VLA-4 molecule in T cell costimulation. Identification of the tyrosine phosphorylation pattern induced by the ligation of VLA-4. J. Immunol. 155, 2938\u20132947 (1995).","journal-title":"J. Immunol."},{"key":"20658_CR29","doi-asserted-by":"publisher","first-page":"e83786","DOI":"10.1371\/journal.pone.0083786","volume":"9","author":"T Ishikawa","year":"2014","unstructured":"Ishikawa, T. et al. Phase I clinical trial of fibronectin CH296-stimulated T cell therapy in patients with advanced cancer. PLoS ONE 9, e83786 (2014).","journal-title":"PLoS ONE"},{"key":"20658_CR30","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/cgt.2008.21","volume":"15","author":"SS Yu","year":"2008","unstructured":"Yu, S. S. et al. In vivo persistence of genetically modified T cells generated ex vivo using the fibronectin CH296 stimulation method. Cancer Gene Ther. 15, 508\u2013516 (2008).","journal-title":"Cancer Gene Ther."},{"key":"20658_CR31","doi-asserted-by":"publisher","first-page":"E7788","DOI":"10.1073\/pnas.1610544113","volume":"113","author":"LV Hurton","year":"2016","unstructured":"Hurton, L. V. et al. Tethered IL-15 augments antitumor activity and promotes a stem-cell memory subset in tumor-specific T cells. Proc. Natl Acad. Sci. USA 113, E7788\u2013E7797 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"20658_CR32","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.stemcr.2014.09.014","volume":"3","author":"G Uenishi","year":"2014","unstructured":"Uenishi, G. et al. Tenascin C promotes hematoendothelial development and T lymphoid commitment from human pluripotent stem cells in chemically defined conditions. Stem Cell Rep. 3, 1073\u20131084 (2014).","journal-title":"Stem Cell Rep."},{"key":"20658_CR33","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.stemcr.2016.01.005","volume":"6","author":"S Kitayama","year":"2016","unstructured":"Kitayama, S. et al. Cellular adjuvant properties, direct cytotoxicity of re-differentiated V\u03b124 invariant NKT-like cells from human induced pluripotent stem cells. Stem Cell Rep. 6, 213\u2013227 (2016).","journal-title":"Stem Cell Rep."},{"key":"20658_CR34","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1016\/j.stemcr.2018.04.025","volume":"10","author":"N Ueda","year":"2018","unstructured":"Ueda, N. et al. Generation of TCR-expressing innate lymphoid-like helper cells that induce cytotoxic T cell-mediated anti-leukemic cell response. Stem Cell Rep. 10, 1935\u20131946 (2018).","journal-title":"Stem Cell Rep."},{"key":"20658_CR35","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.it.2016.09.008","volume":"37","author":"PM Brauer","year":"2016","unstructured":"Brauer, P. M., Singh, J., Xhiku, S. & Z\u00fa\u00f1iga-Pfl\u00fccker, J. C. T cell genesis: in vitro veritas est? Trends Immunol. 37, 889\u2013901 (2016).","journal-title":"Trends Immunol."},{"key":"20658_CR36","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/ni927","volume":"4","author":"Y Wakabayashi","year":"2003","unstructured":"Wakabayashi, Y. et al. Bcl11b is required for differentiation and survival of alphabeta T lymphocytes. Nat. Immunol. 4, 533\u2013539 (2003).","journal-title":"Nat. Immunol."},{"key":"20658_CR37","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1084\/jem.20091430","volume":"207","author":"ML Janas","year":"2010","unstructured":"Janas, M. L. et al. Thymic development beyond beta-selection requires phosphatidylinositol 3-kinase activation by CXCR4. J. Exp. Med. 207, 247\u2013261 (2010).","journal-title":"J. Exp. Med."},{"key":"20658_CR38","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/ni.1830","volume":"11","author":"PC Trampont","year":"2010","unstructured":"Trampont, P. C. et al. CXCR4 acts as a costimulator during thymic beta-selection. Nat. Immunol. 11, 162\u2013170 (2010).","journal-title":"Nat. Immunol."},{"key":"20658_CR39","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.cell.2012.01.049","volume":"149","author":"L Calder\u00f3n","year":"2012","unstructured":"Calder\u00f3n, L. & Boehm, T. Synergistic, context-dependent, and hierarchical functions of epithelial components in thymic microenvironments. Cell 149, 159\u2013172 (2012).","journal-title":"Cell"},{"key":"20658_CR40","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/leu.2015.247","volume":"30","author":"D Sommermeyer","year":"2016","unstructured":"Sommermeyer, D. et al. Chimeric antigen receptor-modified T cells derived from defined CD8+ and CD4+ subsets confer superior antitumor reactivity in vivo. Leukemia 30, 492\u2013500 (2016).","journal-title":"Leukemia"},{"key":"20658_CR41","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.stem.2019.02.005","volume":"24","author":"H Xu","year":"2019","unstructured":"Xu, H. et al. Targeted disruption of HLA genes via CRISPR-Cas9 generates iPSCs with enhanced immune compatibility. Cell Stem Cell 24, 566\u2013578.e7 (2019).","journal-title":"Cell Stem Cell"},{"key":"20658_CR42","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/s41587-019-0016-3","volume":"37","author":"T Deuse","year":"2019","unstructured":"Deuse, T. et al. Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients. Nat. Biotechnol. 37, 252\u2013258 (2019).","journal-title":"Nat. Biotechnol."},{"key":"20658_CR43","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/nbt.3860","volume":"35","author":"GG Gornalusse","year":"2017","unstructured":"Gornalusse, G. G. et al. HLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by NK cells. Nat. Biotechnol. 35, 765\u2013772 (2017).","journal-title":"Nat. Biotechnol."},{"key":"20658_CR44","doi-asserted-by":"crossref","unstructured":"Iriguchi, S. et al. Feeder-free differentiation and expansion for T cells from induced pluripotent stem cells. Protoc. Exch. (2020).","DOI":"10.21203\/rs.3.pex-1271\/v1"},{"key":"20658_CR45","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/S0301-472X(03)00260-1","volume":"31","author":"T Kitamura","year":"2003","unstructured":"Kitamura, T. et al. Retrovirus-mediated gene transfer and expression cloning: powerful tools in functional genomics. Exp. Hematol. 31, 1007\u20131014 (2003).","journal-title":"Exp. Hematol."},{"key":"20658_CR46","doi-asserted-by":"publisher","first-page":"7430","DOI":"10.1128\/JVI.69.12.7430-7436.1995","volume":"69","author":"FL Cosset","year":"1995","unstructured":"Cosset, F. L., Takeuchi, Y., Battini, J. L., Weiss, R. A. & Collins, M. K. High-titer packaging cells producing recombinant retroviruses resistant to human serum. J. Virol. 69, 7430\u20137436 (1995).","journal-title":"J. Virol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-20658-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-20658-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-20658-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T18:47:48Z","timestamp":1697568468000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-20658-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,18]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["20658"],"URL":"https:\/\/doi.org\/10.1038\/s41467-020-20658-3","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.739384837.793590820","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,18]]},"assertion":[{"value":"4 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare the following financial competing interests. S.K. is a founder, shareholder, and chief scientific officer at Thyas Co., Ltd. and received research fundings from Takeda Pharmaceutical Co., Ltd., Kyowa Hakko Kirin Co., Ltd., Sumitomo Chemical Co., Ltd., and Thyas Co., Ltd. S.A., M.K., T. Sato., Y.B., T.S., K.N., M.T., Y. Kassai, and A.H. are employees of Takeda Pharmaceutical Co. Ltd. Y.Y. is an employee of Thyas Co. Ltd. The remaining authors declare no competing financial interests. These authors and all other authors declare no other competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"430"}}